Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea
· Delayed Price · Currency is KRW 4,625.00
+355.00 (8.31%)
At close: Mar 21, 2025, 3:30 PM KST
KOSDAQ:318160 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 4,379 | -1,857 | 2,890 | 3,131 | 4,187 | Upgrade
|
| Depreciation & Amortization | 1,906 | 1,803 | 1,861 | 1,539 | 1,151 | Upgrade
|
| Loss (Gain) From Sale of Assets | -12.55 | 218.15 | 19.17 | 63.68 | -0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 372.86 | - | 308.07 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -5 | -10.2 | - | 1,500 | -22.23 | Upgrade
|
| Stock-Based Compensation | - | - | - | 141.91 | 587.01 | Upgrade
|
| Provision & Write-off of Bad Debts | -37.26 | 326.36 | 87.8 | 417.06 | -41.31 | Upgrade
|
| Other Operating Activities | -1,487 | 3,527 | -748.18 | 842.36 | 569.53 | Upgrade
|
| Change in Accounts Receivable | 339.63 | -1,526 | 1,136 | 1,140 | -287.06 | Upgrade
|
| Change in Inventory | 4,384 | 344.4 | -2,516 | -3,192 | -1,638 | Upgrade
|
| Change in Accounts Payable | 1,586 | 202.36 | -1,590 | 3.93 | 259.87 | Upgrade
|
| Change in Other Net Operating Assets | -1,782 | -1,641 | -701.9 | 1,719 | -1,044 | Upgrade
|
| Operating Cash Flow | 9,271 | 1,759 | 437.8 | 7,614 | 3,723 | Upgrade
|
| Operating Cash Flow Growth | 426.97% | 301.84% | -94.25% | 104.51% | -43.81% | Upgrade
|
| Capital Expenditures | -2,024 | -627.84 | -360.31 | -3,725 | -13,230 | Upgrade
|
| Sale of Property, Plant & Equipment | 116.58 | 26.74 | 32.5 | 71.05 | 4.82 | Upgrade
|
| Cash Acquisitions | - | 11,488 | - | - | -198.18 | Upgrade
|
| Divestitures | - | - | - | 202 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.99 | -504.87 | -14.63 | -124.48 | -18.95 | Upgrade
|
| Investment in Securities | -2,159 | -7,402 | 5,033 | -1,072 | 13,395 | Upgrade
|
| Other Investing Activities | -567.52 | -351 | -671.19 | 112.98 | 93.1 | Upgrade
|
| Investing Cash Flow | -4,643 | 2,630 | 4,020 | -4,535 | 45.08 | Upgrade
|
| Short-Term Debt Issued | 3,675 | 1,387 | 5,342 | 4,535 | - | Upgrade
|
| Total Debt Issued | 3,675 | 1,387 | 5,342 | 4,535 | - | Upgrade
|
| Short-Term Debt Repaid | -6,332 | - | -5,008 | - | - | Upgrade
|
| Long-Term Debt Repaid | -165.97 | -6,182 | -14,234 | -217.48 | -404.24 | Upgrade
|
| Total Debt Repaid | -6,498 | -6,182 | -19,242 | -217.48 | -404.24 | Upgrade
|
| Net Debt Issued (Repaid) | -2,823 | -4,795 | -13,900 | 4,317 | -404.24 | Upgrade
|
| Repurchase of Common Stock | -2,796 | -37.25 | - | - | -7,916 | Upgrade
|
| Other Financing Activities | -5 | - | 5 | - | - | Upgrade
|
| Financing Cash Flow | -5,623 | -4,832 | -13,895 | 4,317 | -8,320 | Upgrade
|
| Foreign Exchange Rate Adjustments | 42.6 | 0.58 | 3.59 | 280.38 | -67.06 | Upgrade
|
| Net Cash Flow | -953.01 | -442.28 | -9,434 | 7,676 | -4,619 | Upgrade
|
| Free Cash Flow | 7,247 | 1,131 | 77.49 | 3,889 | -9,507 | Upgrade
|
| Free Cash Flow Growth | 540.50% | 1360.05% | -98.01% | - | - | Upgrade
|
| Free Cash Flow Margin | 25.50% | 4.14% | 0.28% | 11.06% | -33.26% | Upgrade
|
| Free Cash Flow Per Share | 812.60 | 134.03 | 11.07 | 492.62 | -1180.77 | Upgrade
|
| Cash Interest Paid | 920.98 | 913.78 | 494.66 | 315.16 | 99.92 | Upgrade
|
| Cash Income Tax Paid | 791 | 809.63 | 2,074 | 428.79 | 501.9 | Upgrade
|
| Levered Free Cash Flow | 5,630 | 2,010 | -1,015 | 2,592 | -10,510 | Upgrade
|
| Unlevered Free Cash Flow | 5,887 | 2,315 | -730.29 | 2,975 | -10,498 | Upgrade
|
| Change in Net Working Capital | -3,484 | 323.84 | 4,426 | -1,779 | 2,294 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.